Healthcare — the hottest area in AI development

Neuromation
Sep 25, 2018 · 6 min read
Image source

Fast-Track Government Approval

In America, the FDA has emerged as a tentative supporter of AI applications in medical imaging and diagnostics, given recent exciting advances in the field.

Pattern detection

The pipeline of new AI-enabled diagnostic applications is extremely deep, so if anything we should expect to see an acceleration in the number of applications hitting the market in the coming years.

Pharmaceutical Research

Pharmaceutical industry leaders Amgen, GlaxoSmithKline, Merck, Novartis, Pfizer and Sanofi are all pursuing partnerships with AI startups in the area of automated drug discovery.

Neuromation Activity in Healthcare

Neuromation is actively involved in Healthcare research, having published 5 scientific reports in reputable journals on the application of artificial intelligence in the fields of medical imaging and drug discovery. These papers include studies on the use of deep learning in identification of diabetic retinopathy (a leading cause of blindness), breast cancer image analysis and detection of angiodysplasia (a common cause of gastrointestinal bleeding and anemia).

Neuromation Published Papers on Healthcare (medical imaging and drug discovery):

Neuromation

Distributed Synthetic Data Platform for Deep Learning Applications

Neuromation

Written by

https://neuromation.io

Neuromation

Distributed Synthetic Data Platform for Deep Learning Applications